Erratum for Darkoh et al., “Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile”

by Charles Darkoh, Chioma Odo, Herbert L. DuPont
Published 2017-10-01

Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile

by Charles Darkoh, Chioma Odo, Herbert L. DuPont
Published 2016-08-01

Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review

by William D. Chey, Eric D. Shah, Herbert L. DuPont
Published 2020-01-01

Non-O157 Shiga toxin-producing Escherichia coli—A poorly appreciated enteric pathogen: Systematic review

by Evangelia Valilis, Alison Ramsey, Saad Sidiq, Herbert L. DuPont
Published 2018-11-01

The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea

by Hoonmo L Koo, Herbert L DuPont, David B Huang
Published 2009-10-01

Rifaximin Therapy of Irritable Bowel Syndrome

by Hoonmo L. Koo, Saman Sabounchi, David B. Huang, Herbert L. Dupont
Published 2012-01-01

Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule

by Charles Darkoh, Kimberly Plants-Paris, Dayna Bishoff, Herbert L. DuPont
Published 2019-03-01

Bile salt inhibition of host cell damage by Clostridium difficile toxins.

by Charles Darkoh, Eric L Brown, Heidi B Kaplan, Herbert L DuPont
Published 2013-01-01

Rifaximin Therapy of Irritable Bowel Syndrome

by Hoonmo L. Koo, Saman Sabounchi, David B. Huang, Herbert L. DuPont
Published 2012-06-01

Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome.

by Charles Darkoh, Latoya Comer, Getie Zewdie, Stephen Harold, Ned Snyder, Herbert L Dupont
Published 2014-01-01

Rifaximin-mediated changes to the epithelial cell proteome: 2-D gel analysis.

by Caroline Schrodt, Erin E McHugh, Mary Ann Gawinowicz, Herbert L Dupont, Eric L Brown
Published 2013-01-01

High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya

by Micah O. Oyaro, Kimberly Plants-Paris, Dayna Bishoff, Paul Malonza, Christopher S. Gontier, Herbert L. DuPont, Charles Darkoh
Published 2018-09-01

Pulsed-field Gel Electrophoresis for Salmonella Infection Surveillance, Texas, USA, 2007

by Stephen G. Long, Herbert L. DuPont, Linda Gaul, Raouf R. Arafat, Beatrice J. Selwyn, Joan Rogers, Eric Casey
Published 2010-06-01

Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers’ diarrhea

by Qiyun Zhu, Christopher L. Dupont, Marcus B. Jones, Kevin M. Pham, Zhi-Dong Jiang, Herbert L. DuPont, Sarah K. Highlander
Published 2018-11-01

Drug-resistant Diarrheogenic Escherichia coli, Mexico

by Teresa Estrada-García, Jorge F. Cerna, Leova Paheco-Gil, Raúl F. Velázquez, Theresa J. Ochoa, Javier Torres, Herbert L. DuPont
Published 2005-08-01

Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler’s diarrhea: a prospective co...

by Lisa Lindsay, Herbert L. DuPont, Christine L. Moe, Martin Alberer, Christoph Hatz, Amy E. Kirby, Henry M. Wu, Thomas Verstraeten, Robert Steffen
Published 2018-12-01

Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.

by Samuel L Aitken, Tiby B Joseph, Dhara N Shah, Todd M Lasco, Hannah R Palmer, Herbert L DuPont, Yang Xie, Kevin W Garey
Published 2014-01-01

Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infectio...

by Zhi-Dong Jiang, Robert R Jenq, Nadim J Ajami, Joseph F Petrosino, Ashley A Alexander, Shi Ke, Tehseen Iqbal, Andrew W DuPont, Kenneth Muldrew, Yushu Shi, Christine Peterson, Kim-Anh Do, Herbert L DuPont
Published 2018-01-01